In 2025, an electronic eye implant surfaced that promised to restore vision for some patients suffering from age-related macular degeneration. Named the photovoltaic retina implant microarray, or PRIMA for short, it combines a subretinal voltaic chip implant and augmented reality glasses — they work in tandem — to restore sight for those who have otherwise lost it. It is now officially the first-of-its-kind ocular implant to be approved, and the first to receive a "CE" marking for form vision restoration under the European Union Medical Device Regulation. Form vision restoration involves reading letters, numbers, and words, meaning practical vision is restored for those using the technology. It has already received breakthrough device designation and humanitarian use device designation from the FDA.